Pharmacokinetics and Toxicokinetic Considerations - Vol II
eBook - ePub

Pharmacokinetics and Toxicokinetic Considerations - Vol II

  1. 814 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Pharmacokinetics and Toxicokinetic Considerations - Vol II

About this book

Pharmacokinetics and Toxicokinetic Considerations explains the central principles, cutting-edge methodologies, and incipient thought processes applied to toxicology research. As part of the Advances in Pharmaceutical Product Development and Research series, the book provides expert literature on dose, dosage regimen and dose adjustment, medication errors, and approaches for its prevention, the concept of pharmacotherapy, and managed care in clinical interventions. It expounds on strategies to revamp the pharmacokinetics of the drug and the factors affecting the stability of drugs and their metabolites in biological matrices. Finally, the book offers focused elaborations on various bioanalytical methods for bioavailability and bioequivalence assessment and integrates the wide-ranging principles and concepts shared by toxicokinetics and pharmacodynamics as mutual crosstalk rather than isolated observations. It will be helpful to researchers and advanced students working in the pharmaceutical, cosmetics, biotechnology, food, and related industries including toxicologists, pharmacists, and pharmacologists. - Allows readers to systematically integrate up-to-date research findings into their laboratory work - Presents focused explorations of bioanalytical methods for bioavailability and bioequivalence assessment - Provides clinical applications of concepts

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Pharmacokinetics and Toxicokinetic Considerations - Vol II by Rakesh Kumar Tekade in PDF and/or ePUB format, as well as other popular books in Medicine & Pharmaceutical, Biotechnology & Healthcare Industry. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Cover
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contents
  7. List of contributors
  8. List of Illustrations
  9. List of Tables
  10. Chapter 1 : Principles and concepts in toxicokinetic
  11. Chapter 2 : Factors influencing drug toxicity
  12. Chapter 3 : Molecular biology of apoptotic, necrotic, and necroptotic cell death
  13. Chapter 4 : Toxicogenomics in drug safety assessment
  14. Chapter 5 : Understanding the concept of signal toxicity and its implications on human health
  15. Chapter 6 : Importance of toxicity testing in drug discovery and research
  16. Chapter 7 : Methods and models for in vitro toxicity
  17. Chapter 8 : New emerging technologies for genetic toxicity testing
  18. Chapter 9 : Zebrafish models for toxicological screening
  19. Chapter 10 : Impact of ageing on the pharmacokinetics and pharmacodynamics of the drugs
  20. Chapter 11 : Food–drug interactions and their implications on oral drug bioavailability
  21. Chapter 12 : Drug–drug interactions and their implications on the pharmacokinetics of the drugs
  22. Chapter 13 : Clinical importance of herb–drug interaction
  23. Chapter 14 : In silico methods for the prediction of drug toxicity
  24. Chapter 15 : Organ-on-chip for assessing environmental toxicants
  25. Chapter 16 : Toxicity and toxicokinetic considerations in product development and drug research
  26. Chapter 17 : Drug toxicity and forensic pharmacokinetics
  27. Chapter 18 : Excipient toxicity and safety
  28. Chapter 19 : Pharmaceutical excipients: special focus on adverse interactions
  29. Chapter 20 : Emerging role of novel excipients in drug product development and their safety concerns
  30. Chapter 21 : Toxicity of pharmaceutical azo dyes
  31. Chapter 22 : Environmental and safety aspects of bionanotechnology
  32. Chapter 23 : Toxicological assessment of risk of medical devices
  33. Chapter 24 : Developmental toxicity of nanomaterials used in drug delivery: understanding molecular biomechanics and potential remedial measures
  34. Chapter 25 : Ethical defilements in clinical research and potential roles of institutional review board
  35. Chapter 26 : Toxicokinetic and toxicodynamic considerations in drug research
  36. Index
  37. A